Endo International (ENDP) Has Catalysts Despite NT Weakness - Guggenheim
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Oppenheimer Remains Sidelined as Endo Int'l (ENDP) Shares Trade Down
March 21, 2016 10:08 AM EDTOppenheimer reiterated a Perform rating on Endo International plc (NASDAQ: ENDP) as shares trade down following Valeant's announcement that it was reducing its guidance. Endo management also announced a 1Q16 guidance revision. Management slightly decreased 1Q revenue guidance to ~21-22% of FY16 total revenues, and outlined sales of ~$928-$972M (vs. prior ~22% of... More
Endo Int'l (ENDP), Horizon (HZNP), Mallinckrodt (MNK) on Watch with Valeant (VRX) Halted
March 21, 2016 8:30 AM EDTEndo Int'l (NASDAQ: ENDP), Horizon Pharma (NASDAQ: HZNP) and Mallinckrodt (NYSE: MNK) are on watch with Valeant halted, news pending
UPDATE: Endo (ENDP) Downgraded From Top Pick to Outperform at RBC Following Recent Update
March 18, 2016 6:38 AM EDT(Updated - March 18, 2016 8:37 AM EDT)
RBC Capital downgraded Endo International plc (NASDAQ: ENDP) from Top Pick to Outperform with a price target of $47.00 (from $73.00). Analyst Randall Stanicky noted that shares are down 29% due to a sector pull-back tied to Valeant Pharma's sell-off. Endo also recently... More
